🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The purpose of this research is to determine whether bladder cancer monitor...
Status
Recruiting
Location
West Haven VA Medical Center
Start Date
2023-11-17
Trial ID
NCT05796375
Treatments Being Tested
Recent data suggest that sperm cells carry an epigenetic message during spe...
Status
Unknown
Location
CHU Dijon Bourgogne
Start Date
2016-09
Trial ID
NCT03262207
Methylation detection of circulating free DNA to identify markers for diagn...
Status
Unknown
Location
Peking Union Medical College Hospital
Start Date
2019-08-20
Trial ID
NCT04220710
Treatments Being Tested
1. To carry out research on minimal residual disease (MRD) monitoring in pa...
Status
Unknown
Location
Institute of Hematology and Blood Diseases Hospital Chinese Academy of Medical Sciences
Start Date
2022-08-31
Trial ID
NCT05578625
Treatments Being Tested
This study plan to enroll 852 patients with pulmonary nodules smaller than ...
Status
Unknown
Location
Multiple Locations
Start Date
2022-05
Trial ID
NCT05380999
Treatments Being Tested
Brief Summary (Plain-Language Version - Compliant with ClinicalTrials.gov G...
Status
Completed
Location
University Hospital of Nancy (CHRU de Nancy)
Start Date
2018-02-12
Trial ID
NCT03311152
Treatments Being Tested
Donor-derived cell-free DNA (dd-cfDNA) has been proposed as a potential dia...
Status
Recruiting
Location
Pitié-Salpétriêre Hospital
Start Date
2024-09-02
Trial ID
NCT06026592
In the proposed study, three objectives will be pursued: 1. To develop a m...
Status
Recruiting
Location
Medical Faculty - University of Ljubljana
Start Date
2023-03-23
Trial ID
NCT05765864
Treatments Being Tested
Hepatocellular Carcinoma (HCC) is the fifth most common cancer world-wide. ...
Status
Completed
Location
Infectious Diseases Division
Start Date
2018-08-20
Trial ID
NCT03483922
Treatments Being Tested